Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. Attorney warns of gainsharing risks

This article was originally published in The Gray Sheet

Executive Summary

U.S. Attorney James Sheehan warns that gainsharing is "fraught with risk" stemming from the implications of the anti-kickback statute and the Stark law in such arrangements. At the Medical Device Regulatory and Compliance Congress in Cambridge, Mass. on March 29, Sheehan advised device companies to proceed with caution as they move beyond the gainsharing demonstration project called for in the Deficit Reduction Act of 2005. The demonstration project allows physicians to share in hospital cost savings if they agree to follow certain cost-cutting measures, such as using specific products for which hospitals have negotiated lower prices (1"The Gray Sheet" Jan. 2, 2006, p. 10)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023402

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel